Completed NA INTERVENTIONAL 2-arm NCT03537248

A Safety and Effectiveness Study of a New Multi-Purpose Contact Lens Care Solution

Clinical Safety and Effectiveness of ASP-57 Multi-Purpose Contact Lens Care Solution Compared to a Marketed Contact Lens Solution

Sponsor: Asepticys LLC

Conditions Contact Lens Wear

Interventions ASP-57 ReNu® Multiplus

Updated 8 times since 2018 Last updated: Feb 7, 2019 Started: Apr 23, 2018 Primary completion: Oct 30, 2018 Completion: Oct 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03537248, this NA trial focuses on Contact Lens Wear and remains completed. Sponsored by Asepticys LLC, it has been updated 8 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Feb 2020 — Jan 2021 [monthly]

Completed NA

▶ Show 3 earlier versions

Mar 2019 — Feb 2020 [monthly]

Completed NA

Status: Recruiting → Completed
Jul 2018 — Mar 2019 [monthly]

Recruiting NA
Jun 2018 — Jul 2018 [monthly]

Recruiting NA

First recorded

Apr 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Asepticys LLC

Data source: Asepticys LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Athens, United States , Bloomington, United States , Havre de Grace, United States , Irvine, United States , Longwood, United States , Maitland, United States , Memphis, United States , Nashville, United States , Orlando, United States , Pittsburg, United States and 4 more locations